Multiple myeloma · 24 regimens
Cost vs Efficacy · 2 points
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
BiRd Variant #01 | — | R 31 505 | 28d | 23.0 mo | — | 2 | R 47 614 PFS proxy | 1 |
Lenalidomide and Dexamethasone (RD) Variant #02 | — | R 5 879 | 28d | — | — | ~13 | ~R 76 427 indirect | — |
C-VAMP Variant #01 | — | R 5 801 | 21d | — | — | ~2 | ~R 11 602 indirect | — |
VAMP Variant #04 | — | R 4 534 | 21d | — | — | ~2 | ~R 9 067 indirect | — |
VAD Variant #02 | — | R 2 493 | 28d | — | — | ~5 | ~R 8 297 indirect | — |
VBMCP/VBAD Variant #01 Partial | — | R 2 099 | 35d | — | — | ~2 | ~R 4 199 indirect | — |
DECA Variant #01 | — | R 1 863 | 21d | — | — | ~2 | ~R 3 727 indirect | — |
Cyclophosphamide monotherapy Variant #01 | — | R 1 680 | 28d | — | ~15.8 mo | ~1 | ~R 1 680 PFS proxy · indirect | 1 |
DEX-IFN Variant #01 Partial | — | R 1 389 | 42d | — | — | ~12 | ~R 5 555 indirect | — |
Dexamethasone monotherapy Variant #03 | — | R 1 215 | 28d | — | — | ~4 | ~R 4 861 indirect | — |
VMCP/VCAP Variant #01 | — | R 704 | 21d | — | — | ~6 | ~R 3 028 indirect | — |
VMCP/VBAP Variant #01 Partial | — | R 679 | 21d | — | — | ~6 | ~R 2 577 indirect | — |
CVP Variant #01 | — | R 613 | 21d | — | — | ~8 | ~R 4 901 indirect | — |
mCOP/MP Variant #01 | — | R 581 | 42d | — | 44.0 mo | 2 | R 1 162 PFS proxy | — |
VMCP Variant #01 | — | R 560 | 30d | — | 47.6 mo | 2 | R 1 119 PFS proxy | 1 |
VBMCP Variant #01 Partial | — | R 527 | 35d | — | — | ~2 | ~R 1 053 indirect | — |
ABCM Variant #01 Partial | — | R 498 | 42d | — | 32.0 mo | 12 | R 5 980 PFS proxy | — |
Melphalan and Dexamethasone Variant #05 | — | R 433 | 42d | — | ~45.5 mo | ~19 | ~R 8 232 PFS proxy · indirect | 2 |
Melphalan and Prednisone (MP) Variant #18 | — | R 132 | 42d | — | 29.1 mo | 10 | R 1 102 PFS proxy | 2 |
MP (Prednisolone) Variant #01 | — | R 119 | 28d | — | — | ~13 | ~R 1 544 indirect | — |
Melphalan monotherapy Variant #01 | — | R 73 | 42d | ~50.0 mo | — | ~9 | ~R 660 PFS proxy · indirect | 4 |
VBMC Partial | — | — | — | — | — | — | — | — |
M-DEX Partial | — | — | — | — | — | — | — | — |
EDAP Partial | — | — | — | — | — | — | — | — |
24 of 24 regimens shown